4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-25-001813
Director sold 50,000 shares at $4.00 ($200,000)
From the SEC's structured data for this filing
Trades in this filing
Pacala Mark L · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-18 | Sale : show line 1 in the form | −2,160 | $4.00 | $8,640 | 222,811 | D |
| 2025-11-18 | Sale : show line 2 in the form | −1,210 | $4.00 | $4,840 | 221,601 | D |
| 2025-11-18 | Sale : show line 3 in the form | −46,630 | $4.00 | $186,520 | 174,971 | D |
| Open-market sales · 50,000 sh · avg $4.00 · $200,000 | ||||||
Loading xslF345X05/ownership.xml…